LQDA - Liquidia says FDA review for new Yutrepia indication extended
2024-01-25 06:48:59 ET
More on Liquidia
- Chris DeMuth Sure Likes Uranium And SHF Holdings + 3 Litigation Ideas
- Liquidia Gains Edge In PAH Market Following Key Legal Victory
- Liquidia Corporation (LQDA) Q3 2023 Earnings Call Transcript
- Liquidia announces updates to operations leadership
- Liquidia jumps on win in patent case against United Therapeutics (update)